Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Steinebach

Showing results (1-10 of 40) with videos related to

Pageof 4
Sort By:
Chemical Society Reviews|April 8, 2022
E3 ligase ligand chemistries: from building blocks to protein degradersIzidor Sosič, Aleša Bricelj, Christian Steinebach
Frontiers in Chemistry|July 22, 2021
E3 Ligase Ligands in Successful PROTACs: An Overview of Syntheses and Linker Attachment PointsAleša Bricelj, Christian Steinebach, Robert Kuchta, et al.
Pharmacology & Therapeutics|February 5, 2025
Targeting TAK1: Evolution of inhibitors, challenges, and future directionsNika Strašek Benedik, Matic Proj, Christian Steinebach, et al.
Archiv Der Pharmazie|June 26, 2021
Another structural correction for 1-oxo-1H-phenalene-2,3-dicarbonitriles: Synthesis of a potent BCL-2 inhibiting 7-phenoxy derivativeIzidor Sosič, Martina Gobec, Christian Steinebach, et al.
Journal of Visualized Experiments : Jove|June 4, 2019
Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACsStefanie Lindner, Christian Steinebach, Hannes Kehm, et al.
RSC Advances|July 21, 2025
OSMI-4-based PROTACs do not influence <i>O</i>-GlcNAc transferase and <i>O</i>-GlcNAcylation levels in cellsAleša Bricelj, Doroteja Novak, Lara Smrdel, et al.
Cancers|January 25, 2025
PROTAC-Mediated GSPT1 Degradation Impairs the Expression of Fusion Genes in Acute Myeloid LeukemiaAlicia Perzolli, Christian Steinebach, Jan Krönke, et al.
Pharmaceutics|January 21, 2023
Solubility Enhanced Formulation Approaches to Overcome Oral Delivery Obstacles of PROTACsFlorian Pöstges, Kevin Kayser, Jan Appelhaus, et al.
Chemmedchem|November 3, 2016
Synthesis and Antiangiogenic Properties of Tetrafluorophthalimido and Tetrafluorobenzamido Barbituric AcidsAgnieszka Ambrożak, Christian Steinebach, Erin R Gardner, et al.
Chemical Communications (Cambridge, England)|January 23, 2025
Degrading the key component of the inflammasome: development of an NLRP3 PROTACTim Keuler, Dominic Ferber, Jonas Engelhardt, et al.
Pageof 4

Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
Chemical Society Reviews|April 8, 2022
E3 ligase ligand chemistries: from building blocks to protein degradersIzidor Sosič, Aleša Bricelj, Christian Steinebach
Frontiers in Chemistry|July 22, 2021
E3 Ligase Ligands in Successful PROTACs: An Overview of Syntheses and Linker Attachment PointsAleša Bricelj, Christian Steinebach, Robert Kuchta, et al.
Pharmacology & Therapeutics|February 5, 2025
Targeting TAK1: Evolution of inhibitors, challenges, and future directionsNika Strašek Benedik, Matic Proj, Christian Steinebach, et al.
Archiv Der Pharmazie|June 26, 2021
Another structural correction for 1-oxo-1H-phenalene-2,3-dicarbonitriles: Synthesis of a potent BCL-2 inhibiting 7-phenoxy derivativeIzidor Sosič, Martina Gobec, Christian Steinebach, et al.
Journal of Visualized Experiments : Jove|June 4, 2019
Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACsStefanie Lindner, Christian Steinebach, Hannes Kehm, et al.
RSC Advances|July 21, 2025
OSMI-4-based PROTACs do not influence <i>O</i>-GlcNAc transferase and <i>O</i>-GlcNAcylation levels in cellsAleša Bricelj, Doroteja Novak, Lara Smrdel, et al.
Cancers|January 25, 2025
PROTAC-Mediated GSPT1 Degradation Impairs the Expression of Fusion Genes in Acute Myeloid LeukemiaAlicia Perzolli, Christian Steinebach, Jan Krönke, et al.
Pharmaceutics|January 21, 2023
Solubility Enhanced Formulation Approaches to Overcome Oral Delivery Obstacles of PROTACsFlorian Pöstges, Kevin Kayser, Jan Appelhaus, et al.
Chemmedchem|November 3, 2016
Synthesis and Antiangiogenic Properties of Tetrafluorophthalimido and Tetrafluorobenzamido Barbituric AcidsAgnieszka Ambrożak, Christian Steinebach, Erin R Gardner, et al.
Chemical Communications (Cambridge, England)|January 23, 2025
Degrading the key component of the inflammasome: development of an NLRP3 PROTACTim Keuler, Dominic Ferber, Jonas Engelhardt, et al.
Pageof 4